Mersana Therapeutics buy Truist Financial Co.
Start price
21:00
/
50%
€0.26
Target price
14.08.26
€30.74
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.08.26. The prediction end date can be changed by Truist_Financial_Co_ at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Mersana Therapeutics | - |
| iShares Core DAX® | 1.043% |
| iShares Nasdaq 100 | 1.920% |
| iShares Nikkei 225® | 4.840% |
| iShares S&P 500 | 1.567% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target lowered by analysts at Truist Financial Corporation from $250.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€0.30
16.05.25
16.05.25
€8.93
16.05.26
16.05.26
-13.68%
25.07.25
25.07.25
Mersana Therapeutics
Start price
Target price
Perf. (%)
€5.00
29.02.24
29.02.24
€8.30
28.02.25
28.02.25
-90.28%
01.03.25
01.03.25